Colorectal Cancer Screening and Surveillance Colonoscopy in Older Adults
- 48 Downloads
Purpose of review
The purpose of this chapter is to highlight current recommendations regarding colorectal cancer (CRC) screening and post-polypectomy surveillance colonoscopy in older adults and to review the available literature in order to help inform decision-making in this age group.
Age is a risk factor for CRC; however, older adults with a history of prior screening are at lower risk for CRC compared to those who have never been screened. Decision-making for CRC screening and post-polypectomy surveillance colonoscopy in older adults is complex and several factors including age, screening history, comorbidities, functional status, bowel preparation, prior experiences, preferences, and barriers need to be considered when weighing risks and benefits. Recent guidelines have started to incorporate life expectancy and prior screening history into their recommendations; however, how to incorporate these factors into actual clinical practice is less clear.
There are limited data on the relative benefits of screening and surveillance in older adults and therefore, at this time, decision-making should be individualized and incorporate patient preferences in addition to medical factors.
KeywordsColon cancer Elderly Screening Surveillance
Compliance with Ethical Standards
Conflict of Interest
Jennifer K. Maratt declares that she has no conflict of interest. Audrey H. Calderwood declares that she has no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
References and Recommended Reading
Papers of particular interest, published recently, have been highlighted as: •• Of major importance
- 1.Noone AM, Howlader N, Krapcho M, et al. SEER Cancer Statistics Review, 1975–2015, National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/csr/1975_2015/. Accessed 25 Oct 2018.
- 4.Census Bureau US. Older people projected to outnumber children for first time in U.S. History. https://www.census.gov/newsroom/press-releases/2018/cb18-41-population-projections.html. Accessed 25 Oct 2018.
- 5.Siegel RL, Miller KD, Fedewa SA, Ahnen DJ, Meester RGS, Barzi A, et al. Colorectal cancer statistics, 2017. CA A Cancer J Clin. 2017;67:177–93.Google Scholar
- 6.World Health Organization. World Report on Ageing And Health. Geneva, Switzerland: World Health Organization, 2015; 1–246.Google Scholar
- 7.American Cancer Society. Colorectal cancer facts & figures 2017–2019. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/colorectal-cancer-facts-and-figures/colorectal-cancer-facts-and-figures-2017-2019.pdf. Accessed 25 Oct 2018.
- 9.••Tran AH, Man Ngor EW, Wu BU. Surveillance colonoscopy in elderly patients. JAMA Intern Med. 2014;174:1675–82 Large retrospective cohort of adults 50 years of age or greater undergoing surveillance colonoscopy for history of CRC or polyps showing a low incidence of CRC and a high rate of post procedure hospitalization among older adults (> 75 years).Google Scholar
- 10.Martínez ME, Baron JA, Lieberman DA, Schatzkin A, Lanza E, Winawer SJ, et al. A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy. Gastroenterology. 2009;136:832–41.Google Scholar
- 11.United States Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2008;149:627–37.Google Scholar
- 12.Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, et al. Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force. Ann Intern Med. 2018;149:659–69.Google Scholar
- 13.•• van Hees F, Habbema JDF, Meester RG, Lansdorp-Vogelaar I, van Ballegooijen M, Zauber AG. Should colorectal Cancer screening be considered in elderly persons without previous screening? Ann Intern Med. 2014;160:750–32 Microsimulation modeling study to determine age up to which to consider CRC screening. In unscreened older adults, screening found to be cost-effective up to age 86 in those without comorbidities, up to 83 in those with moderate comorbidities, up to 80 in those with severe comorbidities.CrossRefGoogle Scholar
- 14.•• Rex DK, Boland CR, Dominitz JA, et al. Colorectal cancer screening: recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol. 2017;112:1016–30 The US Multi-Society Task Force recently updated guidelines to include that discontinuation of screening should be considered in individuals who are up to date with screening, who have prior negative screening, reach age 75, or have < 10 years of life expectancy. Also, individuals without prior screening should be considered for screening up to age 85, depending on their age and comorbidities. Finally, they concluded that the decision to continue surveillance should be individualized with consideration of benefit, risk, and comorbidities.CrossRefGoogle Scholar
- 17.••American Cancer Society. Updates on Colorectal Cancer Screening Guideline. https://www.cancer.org/latest-news/american-cancer-society-updates-colorectal-cancer-screening-guideline.html. Accessed 12 Nov 2018. The American Cancer Society states that adults between the ages of 76–85 should make decisions about pursuing screening with their medical provider, with consideration of their own preferences, life expectancy, overall health, and prior screening history. The also recommended against screening for those over the age of 85.
- 18.Cairns SR, Scholefield JH, Steele RJ, Dunlop MG, Thomas HJW, Evans GD, et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut. 2010 Apr 28;59(5):666–89.Google Scholar
- 19.European Colorectal Cancer Screening Guidelines Working Group. European guidelines for quality assurance in colorectal cancer screening and diagnosis. Nov. 2010;17:1–1426.Google Scholar
- 26.Kahn B, Freeland Z, Gopal P, Agrawal D, Mayorga CA, Mithani R, et al. Predictors of guideline concordance for surveillance colonoscopy recommendations in patients at a safety-net health system. Cancer Causes Control. 2015;26:1653–60.Google Scholar
- 31.••Calderwood AH, Anderson JC, Robinson CM, et al. Endoscopist specialty predicts the likelihood of recommending cessation of colorectal cancer screening in older adults. Am J Gastroenterol. 2018 Nov 2. https://doi.org/10.1038/s41395-018-0406-z [Epub ahead of print] Using the New Hampshire Colonoscopy Registry, 85% of adults 70-74 years of age with a normal screening colonoscopy were found to have a recommendation to return for screening (when they would be 80–84 years of age). Advanced age and absence of family history of CRC were associated with recommended to stop screening. Gastroenterologists were more likely to recommend screening cessation for patients of advanced age as compared to non-gastroenterology endoscopists.
- 33.Lin OS, Kozarek RA, Schembre DB, Ayub K, Gluck M, Drennan F, et al. Screening colonoscopy in very elderly patients: prevalence of neoplasia and estimated impact on life expectancy. JAMA. 2006;295:2357–65.Google Scholar
- 35.Kumar A, Lin L, Bernheim O, Bagiella E, Jandorf L, Itzkowitz SH, et al. Effect of functional status on the quality of bowel preparation in elderly patients undergoing screening and surveillance colonoscopy. Gut Liver. 2016;10:569–73.Google Scholar
- 41.•• Le ST, Lash BR, Schroy PC III, et al. Physician perceptions of surveillance follow-up colonoscopy in older adults. J Am Board of Family Med. 2017;30:371–3 Survey-based study of primary care physicians (PCPs) and gastroenterologists that evaluated factors related to decision-making in surveillance for older adults. Factors that PCPs considered life expectancy (40%), gastroenterologists’ recommendations (28%), and patient preferences (12%) as the most important factors while gastroenterologists considered comorbidities (57%), findings on prior colonoscopies (27%), and risks of the procedure (10%) as the most important factors for decision-making.CrossRefGoogle Scholar
- 43.•• Preventive Services US, Task Force B-DK, Grossman DC, et al. Screening for colorectal cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2016;315:2564–75 The US Preventive Services Task Force provides revised guidelines for older adults to include that the decision to screen those who are 76–85 years of age should be individualized. Overall, they concluded that the net benefit of screening individuals in this age group, who have previously been screened, is small and that those who have not been screened are more likely to benefit. They also concluded that screening is most appropriate for those who are healthy enough to undergo treatment and those without comorbid conditions that limit their life expectancy.CrossRefGoogle Scholar